8-item patient-reported outcome measurement information system pediatric short form depressive symptoms promis-d version 1.0 (ProMIS Neurosciences)
Structured Review

8 Item Patient Reported Outcome Measurement Information System Pediatric Short Form Depressive Symptoms Promis D Version 1.0, supplied by ProMIS Neurosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/promis-d-8/pmc11040442-120-22-24?v=ProMIS+Neurosciences
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "Moderating Effect of Depression on Glycemic Control in an eHealth Intervention Among Black Youth With Type 1 Diabetes: Findings From a Multicenter Randomized Controlled Trial"
Article Title: Moderating Effect of Depression on Glycemic Control in an eHealth Intervention Among Black Youth With Type 1 Diabetes: Findings From a Multicenter Randomized Controlled Trial
Journal: JMIR Diabetes
doi: 10.2196/55165
Figure Legend Snippet: Hemoglobin A 1c (HbA 1c ) trajectories by the Patient-Reported Outcome Measurement Information System Pediatric Short Form Depressive Symptoms (PROMIS-D): depressive symptoms low to moderate (<23) versus high (≥23). The high cut-point was 1 SD above the PROMIS-D scale mean at baseline. In the high depressive symptom subgroup, the drops in HbA 1c from baseline to 6 months and from baseline to 18 months were significant ( P <.05).
Techniques Used: